INDV-6200
INDV-6200-101
Phase 1 small_molecule completed
Quick answer
INDV-6200 for Opioid-use Disorder is a Phase 1 program (small_molecule) at Indivior Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Indivior Pharmaceuticals
- Indication
- Opioid-use Disorder
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed